Karolinska Development

Karolinska Development invests in new innovative treatments for life-threatening diseases.

Karolinska Deverlopment’s employees have extensive experience of research, development, financing and commercialisation of pharmaceutical and medtech projects. This expertise enables them to select attractive investment objects, to monitor the development of their portfolio companies, and to ensure that the companies have the right team composition and structure – both in order to progress the projects and to ensure value-generating licensing deals, divestments, or IPOs, based on their successes.